Precision cancer therapies for lung cancer

Lung cancer is the leading cause of cancer death worldwide. Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. In 2024, an estimated 234,580 men and women will be diagnosed with lung cancer in the United States. Lung cancer claims the lives of approximately 125,070 Americans each year. At The University of Kansas Cancer Center, the region's only National Cancer Institute-designated comprehensive cancer center, we take a personalized approach to lung cancer treatment and provide precision cancer therapies specific to each patient. The first step in caring for you begins the moment you call.

Request an appointment today.

888-405-3260

Precision cancer therapy

Our multidisciplinary team of lung cancer specialists designs effective personalized treatment for each patient based on their genetic and molecular characteristics. These precision cancer therapies integrate a patient's tumor molecular data into all treatment decisions.

Nationally renowned experts

Our fellowship-trained physicians provide the most advanced medical and surgical care for lung cancer patients, and access to nationally recognized leading-edge treatment through clinical trials. Our nationally renowned physicians/investigators conduct pivotal research that propels lung cancer care forward, leading to improved treatments and innovative patient care.

Why choose The University of Kansas Cancer Center

The University of Kansas Cancer Center is part of a nationwide network of select cancer research centers established by the National Cancer Institute, part of the National Institutes of Health. NCI-designated cancer centers achieve patient outcomes that are 25% better than those of other centers.
Our multidisciplinary lung cancer treatment comprises lung care specialists in medical oncology, radiation oncology, pulmonology, thoracic surgery, pathology, radiology and research. As the region's largest cancer center, we have 14 locations throughout Kansas City and in Topeka.
We are 1 of fewer than 60 NCI-designated comprehensive cancer centers nationwide. NCI-designated comprehensive cancer centers are the backbone of innovative research and patient care across the country. We treat patients from across the U.S. and around the globe at our multiple locations. Since 2012, we have diagnosed and treated patients from 50 states and 26 countries.